Transplantation Focus

Chemotherapy: the backbone of lymphoma treatment

VJHemOnc is excited to present the latest developments in the role of chemotherapy across lymphomas

The role of MRD in multiple myeloma

VJHemOnc is pleased to bring you a feature exploring the emerging applications of MRD in multiple myeloma.

ASH late-breaking abstract rundown

VJHemOnc is thrilled to bring you the latest updates from the 64th American Society of Hematology (ASH) Annual Meeting and…

ASH press briefing rundown: changing the status quo for blood cancers

VJHemOnc is thrilled to bring you the latest updates from the 64th American Society of Hematology (ASH) Annual Meeting and…

DETERMINATION: the addition of ASCT to lenalidomide, bortezomib, and dexamethasone provides a PFS advantage for patients with newly diagnosed multiple myeloma

For decades, autologous stem cell transplants (ASCTs) with high-dose chemotherapy has been the standard of care for patients with newly…

Genomic testing and clinical decision making in CLL

Learn about the importance of performing genomic testing in CLL and how this impacts diagnosis, prognosis and treatment decisions.

IMW 2021: Heinz Ludwig and Hermann Einsele discuss meeting highlights

VJHemOnc is excited to bring insights from Maria Victoria-Mateos and Irene Ghobrial, as discussed at the 18th International Myeloma Workshop…

IMW 2021: myeloma updates with Maria-Victoria Mateos and Irene Ghobrial

VJHemOnc is excited to bring insights from Maria Victoria-Mateos and Irene Ghobrial, as discussed at the 18th International Myeloma Workshop…

Key trial updates from IMW 2021

VJHemOnc is excited to bring you the latest updates from 18th International Myeloma Workshop (IMW) 2021, which brought together leading…

EHA 2021: updates in myeloid malignancies

VJHemOnc is excited to bring you the latest updates from research investigating the treatment and management of myeloid malignancies, as…

Highlights from the EBMT 2021 virtual meeting

VJHemOnc is excited to bring you highlights from the 47th Annual Meeting of the European Group for Blood and Marrow…

The Post-EBMT for Trainees VJSessions

Join VJHemOnc for an exclusive session with Nico Gagelmann, Claire Horgan and Yasmina Serroukh, who discuss the newly established EBMT…

MDS diagnosis and prognosis with John Bennett

A session with myelodysplastic syndromes (MDS) expert John Bennett who discusses MDS diagnosis and prognosis.

VJSessions: Highlights from the 3rd European EBMT-EHA CAR T-cell Meeting Nurses Programme

A session with experts Erik Aerts, John Murray, Michelle Kenyon & Rose Ellard who cover key areas discussed during the…

The Transplant Sessions: post-ASH 2020 roundtable discussion

A session with experts Bruce Levine and Christian Chabannon, who discuss the exciting updates in transplantation and cell therapy from…

ISA 2020 Top Picks

VJHemOnc are excited to present the latest updates presented at this year’s virtual International Society of Amyloidosis (ISA) 2020 congress….

features: Transplantation